BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21167502)

  • 21. Rapid-onset dystonia-parkinsonism: case report.
    Svetel M; Ozelius LJ; Buckley A; Lohmann K; Brajković L; Klein C; Kostić VS
    J Neurol; 2010 Mar; 257(3):472-4. PubMed ID: 19936820
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial diagnostic workup of parkinsonism: Dopamine transporter positron emission tomography versus susceptibility map-weighted imaging at 3T.
    Sung YH; Lee J; Nam Y; Shin HG; Noh Y; Hwang KH; Lee H; Kim EY
    Parkinsonism Relat Disord; 2019 May; 62():171-178. PubMed ID: 30580909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses.
    Park HK; Kim JS; Im KC; Oh SJ; Kim MJ; Lee JH; Chung SJ; Lee MC
    Mov Disord; 2009 Jan; 24(2):237-45. PubMed ID: 18951539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6).
    Khan NL; Giunti P; Sweeney MG; Scherfler C; Brien MO; Piccini P; Wood NW; Lees AJ
    Mov Disord; 2005 Sep; 20(9):1115-9. PubMed ID: 15954136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction.
    Morales-Briceño H; Ha AD; London K; Farlow D; Chang FCF; Fung VSC
    Parkinsonism Relat Disord; 2019 Jul; 64():319-323. PubMed ID: 30975619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of parkinsonism due to hydrocephalus.
    Racette BA; Esper GJ; Antenor J; Black KJ; Burkey A; Moerlein SM; Videen TO; Kotagal V; Ojemann JG; Perlmutter JS
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1617-9. PubMed ID: 15489399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study.
    Pellecchia MT; Varrone A; Annesi G; Amboni M; Cicarelli G; Sansone V; Annesi F; Rocca FE; Vitale C; Pappatà S; Quattrone A; Barone P
    Mov Disord; 2007 Mar; 22(4):559-63. PubMed ID: 17149727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nigrostriatal dopaminergic function in subjects with isolated action tremor.
    Coria F; Gimenez-Garcia M; Samaranch L; Mora FJ; Sampol-Bas C; Pastor P
    Parkinsonism Relat Disord; 2012 Jan; 18(1):49-53. PubMed ID: 21917500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.
    Brooks DJ; Playford ED; Ibanez V; Sawle GV; Thompson PD; Findley LJ; Marsden CD
    Neurology; 1992 Aug; 42(8):1554-60. PubMed ID: 1641153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Utility of 123-I ioflupane SPECT in the assessment of patients with Parkinsonian syndrome and cerebral vasculopathy].
    García Vicente AM; Vaamonde Cano J; Soriano Castrejón A; Martínez Delgado C; Talavera Rubio P; Poblete García VM; Ruiz Solís S; Rodado Marina S; Cortés Romera M
    Rev Esp Med Nucl; 2005; 24(6):392-403. PubMed ID: 16324516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopa-responsive parkinsonism with normal 6[18F]-fluorodopa positron emission tomography scans.
    Lang AE; Garnett ES
    Ann Neurol; 1990 Oct; 28(4):592-3. PubMed ID: 2252376
    [No Abstract]   [Full Text] [Related]  

  • 33. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Yen TC; Tsai CH; Chen RS; Chang HC
    Mov Disord; 2002 Sep; 17(5):1046-51. PubMed ID: 12360557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked diurnal fluctuation and rest benefit in a patient with parkin mutation.
    Chung SJ; Park HK; Ki CS; Kim MJ; Lee MC
    Mov Disord; 2008 Mar; 23(4):624-6. PubMed ID: 18228570
    [No Abstract]   [Full Text] [Related]  

  • 36. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
    Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
    Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait.
    Lyoo CH; Aalto S; Rinne JO; Lee KO; Oh SH; Chang JW; Lee MS
    Mov Disord; 2007 Nov; 22(15):2176-82. PubMed ID: 17712844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations.
    Przedborski S; Dhawan V; Donaldson DM; Murphy PL; McKenna-Yasek D; Mandel FS; Brown RH; Eidelberg D
    Neurology; 1996 Dec; 47(6):1546-51. PubMed ID: 8960743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease.
    Weise D; Lorenz R; Schliesser M; Schirbel A; Reiners K; Classen J
    Mov Disord; 2009 Aug; 24(11):1669-75. PubMed ID: 19514075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Incidental Finding of Skull Hemangioma During 18F-FP CIT Brain PET/CT.
    Chun KA; Kong E; Cho I
    Clin Nucl Med; 2015 Oct; 40(10):e488-9. PubMed ID: 26284761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.